Nordea Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
65,960
+2,429
+4% +$472K 0.01% 399
2025
Q4
$11.1M Buy
63,531
+218
+0.3% +$39.7K 0.01% 429
2025
Q3
$12.1M Sell
63,313
-164,099
-72% -$29.1M 0.01% 413
2025
Q2
$40.5M Sell
227,412
-1,029,219
-82% -$179M 0.04% 280
2025
Q1
$213M Buy
1,256,631
+732,631
+140% +$120M 0.22% 118
2024
Q4
$79.7M Sell
524,000
-13,456
-3% -$2.09M 0.08% 216
2024
Q3
$83.3M Sell
537,456
-56,848
-10% -$8.49M 0.09% 217
2024
Q2
$82M Sell
594,304
-2,178
-0.4% -$298K 0.1% 221
2024
Q1
$79M Sell
596,482
-17,053
-3% -$2.21M 0.09% 218
2023
Q4
$84.7M Sell
613,535
-385,484
-39% -$50.7M 0.11% 198
2023
Q3
$123M Sell
999,019
-27,008
-3% -$3.6M 0.17% 144
2023
Q2
$145M Buy
1,026,027
+32,105
+3% +$4.43M 0.2% 133
2023
Q1
$139M Buy
993,922
+17,760
+2% +$2.54M 0.2% 131
2022
Q4
$152M Buy
976,162
+73,655
+8% +$10.6M 0.24% 122
2022
Q3
$113M Buy
902,507
+11,594
+1% +$1.53M 0.18% 139
2022
Q2
$121M Buy
890,913
+202,318
+29% +$27.6M 0.18% 143
2022
Q1
$95.7M Buy
688,595
+69,940
+11% +$9.75M 0.12% 179
2021
Q4
$107M Buy
618,655
+42,155
+7% +$6.41M 0.13% 174
2021
Q3
$85.7M Sell
576,500
-1,982,689
-77% -$290M 0.11% 183
2021
Q2
$338M Buy
2,559,189
+199,575
+8% +$26.1M 0.45% 59
2021
Q1
$301M Buy
2,359,614
+628,637
+36% +$77.5M 0.44% 61
2020
Q4
$206M Buy
1,730,977
+286,486
+20% +$34.9M 0.33% 75
2020
Q3
$166M Buy
1,444,491
+825,685
+133% +$97.6M 0.31% 75
2020
Q2
$68.4M Buy
618,806
+454,048
+276% +$48.2M 0.07% 210
2020
Q1
$13.2M Sell
164,758
-308
-0.2% -$31.9K 0.03% 292
2019
Q4
$17.6M Buy
165,066
+10,885
+7% +$1.14M 0.04% 290
2019
Q3
$16.4M Sell
154,181
-2,654
-2% -$272K 0.04% 282
2019
Q2
$16M Buy
156,835
+3,995
+3% +$384K 0.04% 297
2019
Q1
$13.7M Buy
152,840
+17,107
+13% +$1.48M 0.03% 335
2018
Q4
$11.3M Buy
135,733
+127,977
+1,650% +$12M 0.03% 350
2018
Q3
$837K Buy
7,756
+498
+7% +$54.6K ﹤0.01% 1032
2018
Q2
$798K Hold
7,258
﹤0.01% 868
2018
Q1
$728K Sell
7,258
-2,878
-28% -$295K ﹤0.01% 896
2017
Q4
$998K Sell
10,136
-128
-1% -$12.1K ﹤0.01% 802
2017
Q3
$961K Sell
10,264
-458
-4% -$48.6K ﹤0.01% 788
2017
Q2
$1.19M Sell
10,722
-232
-2% -$24.5K ﹤0.01% 765
2017
Q1
$1.08M Sell
10,954
-1,452
-12% -$138K ﹤0.01% 769
2016
Q4
$1.14M Buy
12,406
+4,657
+60% +$401K ﹤0.01% 715
2016
Q3
$656K Buy
7,749
+1,066
+16% +$89.5K ﹤0.01% 789
2016
Q2
$544K Hold
6,683
﹤0.01% 740
2016
Q1
$478K Hold
6,683
﹤0.01% 643
2015
Q4
$475K Sell
6,683
-252
-4% -$16.9K ﹤0.01% 632
2015
Q3
$426K Buy
6,935
+380
+6% +$26.6K ﹤0.01% 580
2015
Q2
$475K Sell
6,555
-38,108
-85% -$2.81M ﹤0.01% 576
2015
Q1
$3.43M Buy
44,663
+1,034
+2% +$74K 0.01% 275
2014
Q4
$2.93M Buy
43,629
+29,676
+213% +$1.87M 0.01% 305
2014
Q3
$847K Hold
13,953
﹤0.01% 519
2014
Q2
$819K Sell
13,953
-688,588
-98% -$40.3M ﹤0.01% 586
2014
Q1
$40.7M Buy
702,541
+139,807
+25% +$7.49M 0.19% 121
2013
Q4
$30.1M Sell
562,734
-1,676,183
-75% -$99.4M 0.15% 134
2013
Q3
$138M Buy
2,238,917
+103,478
+5% +$6.19M 0.77% 32
2013
Q2
$129M Buy
+2,135,439
New +$127M 0.8% 33

Other funds holding DGX

Nordea Investment Management's DGX Position: Q1 2026 in Review

Nordea Investment Management increased its Quest Diagnostics (DGX) stake by 3.8% in Q1 2026, buying an estimated $472K and bringing the position to 65,960 shares worth $12.9M. The position accounts for 0.01% of the portfolio, ranked #399.

Nordea Investment Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $338M in Q2 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Nordea Investment Management held 65,960 shares of Quest Diagnostics worth $12.9M as of Q1 2026.
  • Nordea Investment Management bought 2,429 Quest Diagnostics shares in Q1 2026, an estimated $472K.
  • Quest Diagnostics made up 0.01% of Nordea Investment Management's portfolio in Q1 2026, its #399 holding.
  • Nordea Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Nordea Investment Management's Quest Diagnostics position peaked at $338M in Q2 2021.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.